INVESTIGATION OF RECOMBINANT HUMAN INTERFERON ALPHA-2 (RIFN-ALPHA-2) IN CHRONIC MYELOGENOUS LEUKEMIA (CML)

被引：0
|
作者：
NIEDERLE, N [1 ]
MAHMOUD, HK [1 ]
KLOKE, O [1 ]
BECHER, R [1 ]
机构：
[1] UNIV ESSEN GESAMTHSCH,INNERE KLIN & POLIKLIN TUMORFORSCH,D-4300 ESSEN 1,FED REP GER
来源：
BLUT | 1985年 / 51卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：232 / 232
页数：1
相关论文
共 50 条
  • [1] RECOMBINANT IFN-ALPHA-2 (RIFN-ALPHA-2) FOR TREATMENT OF CHRONIC MYELOGENOUS LEUKEMIA IN BENIGN AND ACCELERATED PHASE
    GASTL, G
    AULITZKY, W
    TILG, H
    LUTTICHAU, I
    MICHLMAYR, G
    GADNER, H
    COSER, C
    SEEWANN, HL
    HUBER, H
    HUBER, C
    BLUT, 1987, 55 (04): : 387 - 387
  • [2] RECOMBINANT IFN-ALPHA-2 (RIFN-ALPHA-2) FOR TREATMENT OF CHRONIC MYELOGENOUS LEUKEMIA IN BENIGN AND ACCELERATED PHASE
    GASTL, G
    AULITZKY, W
    TILG, H
    LUTTICHAU, I
    MICHLMAYR, G
    GADNER, H
    COSER, C
    SEEWANN, HL
    HUBER, H
    HUBER, C
    JOURNAL OF INTERFERON RESEARCH, 1987, 7 (06): : 737 - 737
  • [3] A PHASE-II TRIAL OF RECOMBINANT ALPHA-2 INTERFERON (RIFN-ALPHA-2) IN RENAL-CELL CARCINOMA
    MUSS, HB
    CAPONERA, M
    COOPER, MR
    HOPKINS, J
    JACKSON, DV
    ZEKAN, PJ
    RICHARDS, F
    STUART, JJ
    SPURR, CL
    WHITE, DR
    GREINER, J
    CAPIZZI, RL
    SPIEGEL, RJ
    NERI, R
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1984, 25 (MAR): : 231 - 231
  • [4] SUPPRESSION OF ERYTHROPOIESIS IN PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA BY RECOMBINANT ALPHA-2 INTERFERON
    MCGLAVE, PB
    MAMUS, SW
    CLINICAL RESEARCH, 1985, 33 (04): : A836 - A836
  • [5] Treatment of patients with multiply myeloma (MM) and chronic myelogenous leukemia (CML) with alpha-2 interferon (IFN).
    Bessmeltsev, SS
    Rukavitsyn, OA
    Abdulkadyrov, KM
    EXPERIMENTAL HEMATOLOGY, 1996, 24 (09) : 711 - 711
  • [6] RESULTS OF RECOMBINANT ALPHA-2-C-INTERFERON THERAPY IN PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA (CML)
    KUHRER, I
    LINKESCH, W
    LUDWIG, H
    GISSLINGER, H
    BLUT, 1987, 55 (04): : 390 - 390
  • [7] TREATMENT OF CHRONIC MYELOGENOUS LEUKEMIA WITH RECOMBINANT INTERFERON-ALPHA-2
    DIEDRICH, H
    VONWUSSOW, P
    FREUND, M
    LEBLANC, S
    LINK, H
    WILKE, HJ
    POLIWODA, H
    BLUT, 1986, 53 (03): : 236 - 236
  • [8] RECOMBINANT INTERFERON ALPHA-2B MAINTENANCE AFTER BUSULFAN INDUCTION IN CHRONIC MYELOGENOUS LEUKEMIA (CML)
    FREUND, M
    BLESSMANN, B
    BUCHHOLZ, F
    EISERT, R
    TISCHLER, J
    METZNER, B
    VONWUSSOW, P
    POLIWODA, H
    BLUT, 1988, 57 (04): : 195 - 195
  • [9] TREATMENT OF CHRONIC MYELOGENOUS LEUKEMIA (CML) WITH LOW-DOSES OF RECOMBINANT INTERFERON-ALPHA-2-B
    DIEDRICH, H
    FREUND, M
    VONWUSSOW, P
    EISERT, R
    METZNER, B
    LINK, H
    WILKE, HJ
    SCHMOLL, HJ
    POLIWODA, H
    BLUT, 1987, 55 (04): : 280 - 280
  • [10] CLINICAL INVESTIGATION OF HUMAN ALPHA INTERFERON IN CHRONIC MYELOGENOUS LEUKEMIA
    TALPAZ, M
    KANTARJIAN, HM
    MCCREDIE, KB
    KEATING, MJ
    TRUJILLO, J
    GUTTERMAN, J
    BLOOD, 1987, 69 (05) : 1280 - 1288
12345